Attorney General Jennifer Davenport joined a coalition of 48 states and territories announcing a $29.6 million settlement with Glenmark to resolve allegations that the generic drug manufacturer engaged in a widespread, long-running conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs. New Jersey’s share of today’s multistate settlement is $232,315.61.

“Prescription drug prices are too high—and that’s in no small part because pharmaceutical executives have conspired to raise prices and exploit consumers. The settlement we’re announcing with Glenmark is the latest step in our efforts to drive down the cost of prescription drugs and hold pharmaceutical companies accountable when they violate the law. Consumers should check online or call the hotline to see if they qualify to get some money back as a result of this price-fixing scheme, which led consumers to pay more than they should have for their medicine.” – AG Davenport